Human BCMA/TNFRSF17 DuoSet ELISA DY193 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemHuman BCMA/TNFRSF17 DuoSet ELISA
CompanyR&D Systems, a Bio-Techne Brand
Price $890.00Supplier Page View Company Product Page
Catalog NumberDY193
NCBI Full Gene NameTNF receptor superfamily member 17
NCBI Gene AliasesBCM, BCMA, CD269, TNFRSF13A
StorageStore the unopened product at 2 - 8 °C. Do not use past expiration date
Detection TargetBCMA/TNFRSF17
ReactivityHuman
Detection Range31.20 - 2000 pg/mL
ApplicationsELISA
Quantity1 Kit (for 15 Plates)

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) Plasma cell identity escape drives resistance to anti-BCMA T-cell-redirecting therapy in multiple myelomabioRxivDecember 11, 2025Francesco Maura, Ciara L. Freeman, Kylee H Maclachlan, Marta Larrayoz Larrayoz Ilundain, Bachisio Ziccheddu, Erin W Meermeier, Juan-Jose Garces, Michael Durante, Holly Lee, Ross Firestone, et al.chemotherapy), soluble BCMA (sBCMA) levels were measured using a commercial ELISA kit (R&D Systems, MN, USA; #DY193). Serum samples were serially diluted (between 0–500x) and plates were developed per the manufacturer’s

(2) Young children have limited mucosal immunity when stimulated with an influenza vaccine in tonsil organoidsResearch SquareNovember 26, 2025Mark Davis, Meng Sun, Elsa Solà, Jing Guo, John Valainis, Vishnu Shankar, Lilit Kamalyan, Neha Gupta, Mustafa Ghanizada, Christian Constantz, et al.#AG-45B-0012-KI01; TGF-b1: ThermoFisher, cat #BMS249–4;TACI: R&D Systems, cat #DY174; BCMA: R&D Systems, cat #DY193). Luminex Assay The Luminex assay was performed by the Human Immune Monitoring Center at Stanford

(3) Cilta-cel CAR T cells as an effective and well tolerated treatment for POEMS: a case studyHaematologicaNovember 1, 2025Matthew Williams, Djordje Atanackovic, Rediet Mulatu, Aerielle Matsangos, Daniel Yamoah, Ashraf BadrosBCMA (sBCMA) concentration by enzyme-linked immosorbant assay (R&D Systems, BCMA DuoSet, cat. no. RND-DY193) following the manufacturer’s instructions. The black arrow indicates chimeric antigen receptor (CAR)

(4) Soluble B-cell Maturation Antigen in Multiple Myeloma and Correlation With Response to TherapyAdv HematolOctober 15, 2025Souvik Saha, Prankrishna Kakati, Kulwant Singh, Manish Kumar Singh, Khaliqur Rahman, Sanjeev Yadav, Dinesh Chandra, Ruchi Gupta, Rajesh Kashyapusing enzyme‐linked immunosorbent assay with anti‐BCMA antibody (Human BCMA/TNFRSF 17 DuoSet ELISA DY193—R&D Systems, Minneapolis, USA). Frozen serum samples were thawed and initially tested at a 1:500 dilution.

(5) Prevalence of CCR7-Positive CD8 T Cells as a Prognostic Factor in B-Cell Maturation Antigen -Targeted Chimeric Antigen Receptor T Cell TherapyEJHaemMay 5, 2025Yoshiaki Marumo, Masaki Ri, Toru Ebina, Tomoyuki Nakamura, Yoshiko Oshima, Takahiro Nakashima, Shiori Kinoshita, Tomotaka Suzuki, Tomoko Narita, Takaomi Sanda, et al.analyzed in the plasma samples of each patient on initiation of LDC using a Human BCMA DuoSet ELISA Kit (DY193, R&D Systems, Waltham, MA, USA), with the mean value of triplicate samples calculated for each specimen. 2.3

(6) Serum B-cell maturation antigen could be a simple and accurate biomarker to identify and prognosticate monoclonal gammopathy of undetermined significance and smoldering multiple myelomaHaematologicaMay 1, 2025Masanori Toho, Daisuke Ikeda, Shuichi Aikawa, Chiho Misono, Mitsuaki Oura, Fuminari Fujii, Hajime Sakuma, Atsushi Uehara, R ikako Tabata, Kentaro Narita, et al.enzyme-linked immunosorbent assay with a polyclonal anti-BCMA antibody (Human BCMA/TNFRSF17 DuoSet ELISA DY193 - R&D Systems, Minneapolis, MN, USA). Figure 1A compares sBCMA levels in healthy control (HC) with

(7) Clinical evaluation and determinants of response to HBI0101 (BCMA CART) therapy in relapsed/refractory multiple myeloma∗†Blood AdvancesAugust 13, 2024Shlomit Kfir-Erenfeld, Nathalie Asherie, Eyal Lebel, Vladimir Vainstein, Miri Assayag, Tatyana Dubnikov Sharon, Sigal Grisariu, Batia Avni, Shlomo Elias, Rivka Alexander-Shani, et al.concentration before and after CART infusion was determined using the Human BCMA/TNFRSF17 DuoSet ELISA (DY193, R&D Systems), according to the manufacturer’s instruction. Statistical analysis Kaplan-Meier method

(8) Mechanisms of antigen escape from BCMA- or GPRC5D-targeted immunotherapies in multiple myelomaNature medicineSeptember 1, 2023Lee H, Ahn S, Maity R, Leblay N, Ziccheddu B, Truger M, Chojnacka M, Cirrincione A, Durante M, Tilmont R, et al.

(9) Soluble B-cell maturation antigen as a monitoring marker for multiple myelomaPathology and Oncology ResearchApril 28, 2023Ádám Wiedemann, Virág Réka Szita, Róbert Horváth, Attila Szederjesi, Attila Sebő, András Dávid Tóth, Tamás Masszi, Gergely Vargaenzyme-linked immunosorbent assay with a polyclonal anti-BCMA antibody (Human BCMA/TNFRSF17 DuoSet ELISA DY193—R&D Systems, Minneapolis, MN, United States) was used to measure the sBCMA levels, as previously published

(10) Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line TherapyBlood Cancer DiscoveryMarch 1, 2023Alfred L. Garfall, Adam D. Cohen, Sandra P. Susanibar-Adaniya, Wei-Ting Hwang, Dan T. Vogl, Adam J. Waxman, Simon F. Lacey, Vanessa E. Gonzalez, Joseph A. Fraietta, Minnal Gupta, et al.FACSDiva software (BD Biosciences). Measurement of Soluble BCMA The antibody set for human BCMA (DY193) was from R&D Systems. ELISA 8-bead strip and 4-column reservoir (SOW A16735) were from The Assay Depot

(11) Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple SclerosisNeurology - Neuroimmunology NeuroinflammationMarch 1, 2023Samantha Ho, Eva Oswald, Hoi Kiu Wong, Atay Vural, Vuslat Yilmaz, Erdem Tüzün, Recai Türkoğlu, Tobias Straub, Ingrid Meinl, Franziska Thaler, et al.described.4 Measurement of Soluble Components of the BAFF-APRIL System BAFF (DY124), APRIL (DY884), sBCMA (DY193), and sTACI (DY174) were analyzed in serum and CSF by ELISAs (R&D Systems, Minneapolis, MN). To determine

(12) A Proliferation-Inducing Ligand and B-Cell Activating Factor Are Upregulated in Patients with Essential ThrombocythemiaJournal of clinical medicineAugust 9, 2022Bolkun L, Tynecka M, Wasiluk T, Piszcz J, Starosz A, Grubczak K, Moniuszko M, Eljaszewicz A.

(13) Serum BCMA levels predict outcomes in MGUS and smoldering myeloma patientsBlood cancer journalJune 24, 2021Visram A, Soof C, Rajkumar SV, Kumar SK, Bujarski S, Spektor TM, Kyle RA, Berenson JR, Dispenzieri A.

(14) Characterization of B- and T-Cell Compartment and B-Cell Related Factors Belonging to the TNF/TNFR Superfamily in Patients With Clinically Active Systemic Lupus Erythematosus: Baseline BAFF Serum Levels Are the Strongest Predictor of Response to Belimumab after Twelve Months of TherapyFrontiers in pharmacologyJanuary 1, 2021Piantoni S, Regola F, Masneri S, Merletti M, Lowin T, Airò P, Tincani A, Franceschini F, Andreoli L, Pongratz G.

(15) Preclinical development of a humanized chimeric antigen receptor against B cell maturation antigen for multiple myelomaHaematologicaJanuary 1, 2021Perez-Amill L, Suñe G, Antoñana-Vildosola A, Castella M, Najjar A, Bonet J, Fernández-Fuentes N, Inogés S, López A, Bueno C, et al.

(16) Cerebrospinal Fluid Biomarkers of Myeloid and Glial Cell Activation Are Correlated With Multiple Sclerosis Lesional Inflammatory ActivityFrontiers in neuroscienceJanuary 1, 2021Masvekar R, Phillips J, Komori M, Wu T, Bielekova B.MSD-ECL,R&D Systems (DY4909-05),250 ng/ml and 100 ng/ml,5.8 pg/ml BCMA,Homebrew MSD-ECL,R&D Systems (DY193),400 ng/ml and 400 ng/ml,7 pg/ml CHI3L1,Homebrew MSD-ECL,R&D Systems (DY2599),4 μg/ml and 100 ng/ml,41

(17) A Flexible Multiplatform Bioanalytical Strategy for Measurement of Total Circulating Shed Target Receptors: Application to Soluble B Cell Maturation Antigen Levels in the Presence of a Bispecific Antibody DrugASSAY and Drug Development TechnologiesJanuary 1, 2021Angela Stauffer, Chad Ray, Michael Hallfor sBCMA Human BCMA/TNFRSF17 DuoSet Enzyme-Linked Immunosorbent Assay (ELISA) Kit from R&D Systems (DY193, Minneapolis, MN) was converted to a Meso Scale Discovery (MSD, Rockville, MD) format and evaluated

(18) Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple SclerosisCellsNovember 25, 2020Robinson T, Abdelhak A, Bose T, Meinl E, Otto M, Zettl UK, Dersch R, Tumani H, Rauer S, Huss A.in CSF using commercial ELISA by R&D Systems (BAFF: DBLYS0B; CXCL-13: DCX130; CHI3L1: DC3L10; sBCMA: DY193; and sTACI: DY174). Results of measurements of GFAP, CHI3L1, and NfL in the same PPMS cohort have been

(19) B cell maturation antigen-specific CAR T cells are clinically active in multiple myelomaThe Journal of clinical investigationMarch 21, 2019Cohen AD, Garfall AL, Stadtmauer EA, Melenhorst JJ, Lacey SF, Lancaster E, Vogl DT, Weiss BM, Dengel K, Nelson A, et al.BAFF, and APRIL concentrations in serum was performed by ELISA using antibody sets for human BCMA (DY193), APRIL (DY884B), and BAFF (DT124-05) from R&D Systems. See Supplemental Methods for details. Flow cytometric

(20) Human Plasmacytoid Dendritic Cells Display and Shed B Cell Maturation Antigen upon TLR EngagementJournal of immunology (Baltimore, Md. : 1950)April 15, 2017Schuh E, Musumeci A, Thaler FS, Laurent S, Ellwart JW, Hohlfeld R, Krug A, Meinl E.

Be the First to Write a Review!

BCMA/TNFRSF17 ELISA

Human BCMA/TNFRSF17 DuoSet ELISA

Human BCMA/TNFRSF17 DuoSet ELISA from R&D Systems, a Bio-Techne Brand

R&D Systems, a Bio-Techne Brand

Citations (21)

Reviews

Human BCMA/TNFRSF17 DuoSet ELISA from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map